Glyco-Flex III Tablets

This page contains information on Glyco-Flex III Tablets for veterinary use.
The information provided typically includes the following:
  • Glyco-Flex III Tablets Indications
  • Warnings and cautions for Glyco-Flex III Tablets
  • Direction and dosage information for Glyco-Flex III Tablets

Glyco-Flex III Tablets

This treatment applies to the following species:
Manufacturer: Vetri-Science

A GlycOmega™ Perna Product For Joint and Connective Tissue Support

FOR DOGS

Veterinarian Approved

STAGE III

Product Facts:

Active Ingredients Per Tablet:

Glucosamine HCI (Shrimp and Crab)

1000 mg

Methylsulfonylmethane (MSM)

1000 mg

Perna Canaliculus (GlycOmega™ brand Green Lipped Mussel)

600 mg

N,N-Dimethylglycine HCI (DMG)

100 mg

dl-alpha Tocopheryl Acetate (Vitamin E)

50 IU

Calcium Ascorbate (Vitamin C)

30 mg

Manganese (as Manganese Amino Acid Chelate)

10 mg

Grape Seed Extract

5 mg

L-Glutathione

2 mg

Selenium (as Sodium Selenite)

0.002 mg

Inactive Ingredients

brewers yeast, cellulose, dicalcium phosphate, natural imitation roast chicken flavor, silicon dioxide, stearic acid.

GlycOmega™ is a trademark of Aroma New Zealand Ltd.

Cautions: Safe use in pregnant animals or animals intended for breeding has not been proven.

Consult with your veterinarian before using this product in animals: with clotting disorders; being treated with anticoagulant medications; diabetes, or any metabolic disorder causing hyperglycemia; history of urinary tract stones; known allergies to shellfish.

If lameness worsens, discontinue use and contact your veterinarian.

Administer during or after the animal has eaten to reduce incidence of gastrointestinal upset.

For use in dogs only.

GLYCO-FLEX™ Ill represents Stage III of our comprehensive stage of life program for dogs needing advanced joint support. These delicious natural imitation roast chicken flavored chewable tablets are recommended by veterinarians for dogs with a maximum need for joint and connective tissue support, geriatric and working dogs as well as a follow-up to orthopedic surgery.

Directions For Use

Initial: (4 -6 Weeks)

Up to 30 lbs:

1/2 tablet daily

31 - 60 lbs:

1 tablet daily

61 - 100 lbs:

2 tablets daily

101 lbs and over:

2 1/2 tablets daily

Maintenance: (After initial period)

Up to 30 lbs:

1/2 tablet every other day

31 - 60 lbs:

1/2 tablet daily

61 - 100 lbs:

1 tablet daily

101 lbs and over:

1 1/2 tablets daily

If giving more than 1 tablet, divide between AM and PM.

Warnings

For animal use only.

Keep out of the reach of children and animals. In case of accidental overdose, contact a health professional immediately.

Store in a cool, dry place.

Distributed by Vetri-Science® Laboratories, A Division of FoodScience Corporation, 20 New England Drive, Suite 10, Essex Junction, VT 05452 USA

www.vetriscience.com

1-800-882-9993

Net Wt.

 

 

90 chewable tablets

0900887.090

0210A

120 chewable tablets

0900887.120

0210A

NAC No.: 6166034.2

VETRI-SCIENCE® LABORATORIES
Division of FoodScience Corporation

20 NEW ENGLAND DRIVE, SUITE 10, ESSEX JUNCTION, VT, 05452
Toll-Free:   800-882-9993
Fax:   802-878-0549
Website:   www.vetriscience.com
Email:   info@vetriscience.com
Every effort has been made to ensure the accuracy of the Glyco-Flex III Tablets information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-12-03

(web2)